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012.11.0Abstract Objectives: We set out to explore the prevalence of signiﬁcant atherosclerotic disease of
the internal pudendal arteries (IPA) in diabetic men with erectile dysfunction (ED) and angiograph-
ically documented multi-vessel coronary artery disease (CAD).
Background: ED shares common risk factors of CAD, and is increasingly recognized as a well
established risk factor for future cardiovascular events.
Methods: We enrolled 30 consecutive diabetic patients with ED undergoing elective coronary cath-
eterization. Erectile function was evaluated using the abbreviated 5-item questionnaire known as
the Sexual Health Inventory for Men. Distal aortography was ﬁrst performed, followed by selective
internal iliac arteriography. Signiﬁcant IPA disease was deﬁned as 50% or more luminal obstruc-
tion seen in the projection that best delineates the takeoff of the artery.
Results: The mean age of the whole series was 59.6 ± 8.4 years. The mean duration of diabetes
mellitus was 8.1 ± 7.1 years, and the mean duration of ED was 4.3 ± 3.2 years. Signiﬁcant IPA dis-
ease (stenosis/occlusion) was found in 11 (36.7%) patients; unilateral in 6 (20%) patients, and bilat-
eral in 5 (16.7%) ones.
Signiﬁcant internal iliac artery disease (stenosis/occlusion) was found in 6 (20%) patients; unilateral
in 4 (13.3%) patients, and bilateral in 2 (6.7%) ones. Signiﬁcant IPA disease correlated positively
with age and negatively with estimated creatinine clearance (p < 0.05 for both).
Conclusions: In diabetic male patients with ED who have angiographically documented multi-ves-
sel CAD, signiﬁcant IPA obstruction (stenosis/occlusion) is rather frequent, and it correlates pos-
itively with age, and negatively with the estimated creatinine clearance.
ª 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.gmail.com (A. Shawky).
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031. Introduction
Deﬁned as the repeated inability to achieve and maintain
erection sufﬁcient for satisfactory sexual intercourse, erectile
dysfunction (ED) affects more than 150 million men all overg by Elsevier B.V. All rights reserved.
88 H. Zaki et al.the world.1,2 Although ED is multifactorial in origin vascular
causes are not uncommon, being mostly related to insufﬁcient
arterial inﬂow to the penile arteries, impaired cavernosal
smooth muscle relaxation, or veno-occlusive dysfunction.3 It
was reported that men with ED may have angiographically
documented signiﬁcant atherosclerotic disease of the iliac,
internal pudendal, or cavernosal arteries.4–6 Interestingly, ED
shares common classic risk factors of atherosclerotic coronary
artery disease (CAD), such as aging, diabetes mellitus, hyper-
tension, cigarette smoking, and dyslipidemia.7–9 Furthermore,
ED is increasingly recognized as a well established risk factor
for future cardiovascular events.10 In this respect, it was dem-
onstrated that nearly 70% of men presenting with new onset
angina and angiographically documented CAD had pre-exist-
ing ED.11
The mainstay of therapeutic approach to ED is based on
identiﬁcation and treatment of an underlying cause, in addi-
tion to administration of phosphodiesterase-5 inhibitors. Nev-
ertheless, inadequate response to therapeutic doses of
phosphodiesterase-5 inhibitors was observed in 25–35% of
men with ED; the rate of poor responders is even higher
(40–50%) in diabetic patients.12
In a single-center prospective study design, we sought to ex-
plore the prevalence of signiﬁcant atherosclerotic disease of the
internal pudendal arteries (IPA) in diabetic men with ED and
angiographically documented multi-vessel CAD.Figure 1A Right anterior oblique view with cranial angulation
showing 50% stenosis of the right internal pudendal artery.2. Materials and methods
2.1. Patient selection
Prospectively, we enrolled 30 consecutive diabetic patients
with ED undergoing elective coronary catheterization in our
cath lab during the period from November 2010 to May
2011. Patients underwent elective coronary catheterization
either for suspected CAD, or for recurrent symptoms despite
adequate prior therapy. Patients were considered eligible for
enrollment if they had angiographically documented multi-
vessel signiﬁcant CAD, deﬁned as 50% or more luminal
obstruction of at least three sizable epicardial coronary arteries
(measuring 2.5 mm or more in diameter), seen in 2 different
projections, or at least 50% luminal obstruction of the left
main coronary artery plus signiﬁcant disease in a sizable right
coronary artery.
Diabetes mellitus was deﬁned according to the diagnostic
criteria described by the American Diabetes Association as a
fasting plasma glucoseP126 mg/dl, and/or a 2-h postload glu-
coseP200 mg/dl, or speciﬁc anti-diabetic drug therapy.13 The
presence of hypertension was deﬁned as a systolic blood pres-
sure P140 mmHg and/or a diastolic blood pressure
P90 mmHg, previously recorded by repeated noninvasive
ofﬁce measurements, which leads to life-style modiﬁcation or
antihypertensive drug therapy. Erectile function was evaluated
using the abbreviated 5-item questionnaire known as the Sex-
ual Health Inventory for Men.
These 5 items were scored on a scale of 0–5, and have been
shown to discriminate highly between men with and without
ED with an optimal cutoff score 621 for diagnosis of ED.14
We excluded patients with known nonvascular causes of ED
such as neurogenic EDdue to radiation injury, prior penile trau-
ma, or radical prostatectomy, as well as those with an estimatedcreatinine clearance <60 mL/min. Before enrollment, an in-
formedwritten consent was obtained from each patient after full
explanation of the study protocol, and the protocol was
reviewed and approved by our local Institutional Human
Research Committee as it conforms to the ethical guidelines of
the 1975 Declaration of Helsinki, as revised in 2002.
2.2. Coronary and pelvic artery angiography
Femoral artery access was adopted, and coronary angiography
was performed using the standard technique. If indicated, ad
hoc percutaneous coronary intervention was carried out in
the same session. Pelvic angiography was performed after cor-
onary angiography. Distal aortography was ﬁrst performed
using a pig-tail catheter with its head positioned between the
forth and ﬁfth lumbar vertebrae. Automatic pump injection
was performed in the anteroposterior projection at a rate of
15 mL/s to deﬁne the aorto-iliac bifurcation, common and
internal iliac arteries. Then, selective internal iliac arteriogra-
phy was carried out. The ipsilateral iliac artery was injected
from a straight-head catheter placed retrogradely in the com-
mon iliac artery. The contralateral iliac artery was injected
from a Judkins Right or Williams catheter advanced over a
0.035-inch angled guide wire introduced by the crossover tech-
nique. Before angiography, nitroglycerine was injected
(200 lg) intra-arterially to overcome vasoconstriction fre-
quently encountered with small and medium-sized arteries.
The IPA was seen as a posterior division of the distal internal
iliac artery, with the takeoff best seen in the 30–40 ipsilateral
oblique view. Angiograms were taken in multiple projections
to visualize the entire length of the internal iliac and IPA.
2.3. Quantitative lesion analysis
The outer diameter of a contrast-ﬁlled catheter was used for
calibration. Reference vessel diameter and the percent diame-
ter stenosis were measured using quantitative vessel angiogra-
phy (Inturis Allura, Phillips Medical Systems, Netherlands).
The lesions were analyzed in multiple projections and stenosis
severity measured from the most severe angiographic view.
The reference vessel diameter was measured adjacent to the
stenosis at the most healthy appearing segment. Signiﬁcant
IPA disease was deﬁned as 50% or more luminal obstruction
Figure 1B Anteroposterior view showing total occlusion of the
left internal pudendal artery.
r=0.428      P-value=0.018*
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tery (Fig. 1A and B).
2.4. Statistical analysis
Continuous variables were presented as mean ± SD, if they
were normally distributed. Data were tested for normal distri-
bution using the Kolmogorov–Smirnov test. Categorical vari-
ables were described with absolute and relative (percentage)
frequencies. Pearson’s correlation coefﬁcient test was per-
formed to study the correlation between signiﬁcant IPA dis-
ease and various demographic and clinical variables. A
probability value of p < 0.05 was considered statistically sig-
niﬁcant. Analyses were performed with SPSS version 12.0 sta-
tistical package (SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Baseline clinical characteristics
A total of 30 diabetic male patients with ED and angiographi-
cally documentedmulti-vessel CADwere enrolled in the current
study. The mean age of the whole series was 59.6 ± 8.4 years.
Baseline clinical characteristics are shown in Table 1. The mean
duration of diabetes mellitus was 8.1 ± 7.1 years, and the mean
duration of ED was 4.3 ± 3.2 years. The body mass index ran-
ged from 20.9 to 44.9; 18 patients (60%) were overweight,
6 (20%) were obese, 1 (3.3%) was morbidly obese.Table 1 Baseline clinical characteristics of the study group.
Study group (N = 30)
Age (years) 59.6 ± 8.4
Insulin-dependent diabetes mellitus 7 (23.3%)
Duration of Diabetes (years) 8.1 ± 7.1
Smoking 13 (43.3%)
Hypertension 12 (40%)
Duration of erectile dysfunction (years) 4.3 ± 3.2
Family history of ischemic heart disease 24 (80%)
Body mass index 28.6 ± 4.8
Creatinine clearance (mL/min) 97.2 ± 32.4
Continuous variables are presented as mean ± SD, while categor-
ical variables are presented as numbers (%).3.2. Angiographic data
Signiﬁcant left main coronary artery stenosis was found in 2
(6.7%) patients. Signiﬁcant IPA disease (stenosis/occlusion)
was found in 11 (36.7%) patients; unilateral in 6 (20%) pa-
tients, and bilateral in 5 (16.7%) ones. Signiﬁcant internal iliac
artery disease (stenosis/occlusion) was found in 6 (20%) pa-
tients; unilateral in 4 (13.3%) patients, and bilateral in 2
(6.7%) ones. Signiﬁcant IPA disease was positively correlated
with age (r= 0.428, p= 0.018) (Fig. 2), and negatively corre-
lated with estimated creatinine clearance (r= 0.48,
p= 0.007) (Fig. 3).
4. Discussion
The current study demonstrated that in diabetic male patients
with ED who have angiographically documented multi-vessel
CAD, signiﬁcant IPA obstruction (stenosis/occlusion) is rather
frequent (36.7%), and its presence correlates positively with
age, and negatively with the estimated creatinine clearance.
Moreover, signiﬁcant internal iliac artery obstruction (steno-
sis/occlusion) is not infrequent (20%). Both arterial bed affec-
tions are mostly the consequence of atherosclerosis, and might
probably be implicated in the underlying etiology of ED. The
IPA is the chief source of arterial blood supply to the penis; it
extends as the straight-line continuation of the distal internal
iliac artery.15 Ultimately, the IPA divides into the dorsal pe-
nile, cavernosal, and bulbourethral arteries. The cavernosal
arteries provide blood ﬂow to ﬁll the sinusoids of the corpora
cavernosa, resulting in normal erection. During arousal, para-
sympathetic activation induces relaxation of the smooth mus-
cle ﬁbers in the walls of the sinusoids, leading to a near
sevenfold increase in blood ﬂow.16 During full erection, the
intracavernosal pressure approaches 100 mmHg, a fact which
underscores the importance of adequate arterial inﬂow pres-
sure. During intercourse, contraction of the ischiocavernosal
muscle rigorously augments the intracavernosal pressure to
suprasystolic values.15 Hence, atherosclerotic obstruction
stenosis/occlusion) of the IPA and/or internal iliac artery would
sufﬁciently compromise penile arterial inﬂow, resulting in ED.
Atherosclerosis is a diffuse process that is prone to affect al-










Figure 2 Scattered diagram depicting the correlation between
signiﬁcant internal pudendal artery disease and age IPA indicates
internal pudendal arteries.
















Figure 3 Scattered diagram depicting the correlation between
signiﬁcant internal pudendal artery disease and estimated creat-
inine clearance IPA indicates internal pudendal arteries; Cr Cl,
creatinine clearance.
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more aggressive complications. Therefore, in diabetic patients
with ED, there is good reason to suggest insufﬁciency of penile
arterial inﬂow (internal iliac artery and IPA) as a possible
underlying etiology.
Currently available non-invasive imaging techniques, such
as computed tomography and magnetic resonance angiogra-
phy are inaccurate for the evaluation of the distal segments
of the IPA and its branches. Hence, selective contrast angiog-
raphy is the ‘gold standard’ for diagnosis of atherosclerotic
IPA disease, hitherto. For clear ethical reasons, sole invasive
imaging of the internal iliac artery and IPA was not incorpo-
rated as a part of the routine workup of patients with ED, even
when there is a high index of suspicion (diabetes mellitus).
Thus, we opted to employ invasive imaging in diabetic patients
with ED undergoing invasive evaluation of the coronary arter-
ies. Due to the limited sample size, we hypothesized that exclu-
sive enrollment of patients with multi-vessel CAD (which
speaks of more extensive atherosclerosis) would further in-
crease the diagnostic gain of invasive assessment, by increasing
the pretest likelihood of having atherosclerotic disease of the
pelvic arteries, as well.
The current study enrolled patients with a relatively high-
risk proﬁle: all diabetic with a mean duration of
8.1 ± 7.1 years (23.3% insulin-dependent), 40% hypertensive,
43.3% smokers, 83.3% overweight or obese, all with multi-
vessel CAD. The relative prevalence of IPA and internal iliac
artery disease might bear a strong relationship with the high
prevalence of risk factors for atherosclerosis. This might again
reiterate the prior observation that ED and CAD share com-
mon risk factors, and that ED is a predictor of cardiovascular
events and it precedes symptomatic CAD by 2–3 years.11,17 To
the best of the authors’ knowledge, the current study is among
the ﬁrst ones to report the prevalence of signiﬁcant atheroscle-
rotic disease of the IPA in diabetic patients with ED undergo-
ing invasive coronary catheterization. However, we postulate
that the prevalence would obviously be lower should patients
with lower-risk proﬁle or those representative of real-life prac-
tice have been enrolled.4.1. Clinical implications
Current management of ED essentially involves treatment of
potentially reversible underlying causes, and most often a trial
of phosphodiesterase-5 inhibitor administration. In diabetics,
however, a high rate (40–50%) of poor response to these
agents was previously reported.12 Subsequent therapeutic op-
tions for poor responders are excessively invasive and uncom-
fortable, such as vacuum constrictor devices and penile
prosthesis. Therefore, invasive diagnostic imaging to explore
the presence of signiﬁcant IPA stenosis/occlusion amenable
for percutaneous intervention would be greatly justiﬁed, espe-
cially in diabetic patients with a high index of suspicion (due to
widespread diffuse atherosclerosis affecting various vascular
beds) and a high rate of poor response to conventional therapy
with phosphodiesterase-5 inhibitors. Anecdotal case reports of
percutaneous balloon angioplasty of penile inﬂow arteries
(internal iliac artery and IPA) had been already described be-
fore the introduction of stents, with initial clinical success.18,19
Yet, the major limitation was recurrence, most probably due to
restenosis. A late-breaking report described 3 cases of ED not
responsive to phosphodiesterase-5 inhibitors who were treated
with percutaneous stent implantation in the IPA, and who
experienced a signiﬁcant improvement of erectile function fol-
lowing revascularization.20 Since it extends as a straight-line
continuation of the internal iliac artery, percutaneous access
to the IPA can be easily achieved through the contralateral
femoral (crossover) approach. Hence, we recommend invasive
imaging of the penile inﬂow arteries (internal iliac artery and
IPA) in patients with ED, undergoing elective coronary cathe-
terization, who are poor responders to phosphodiesterase-5
inhibitors, especially those with a high index of suspicion: dia-
betics and those with multi-vessel CAD.
5. Conclusion
In diabetic male patients with ED who have angiographically
documented multivessel CAD, signiﬁcant IPA obstruction
(stenosis/occlusion) is rather frequent, and it correlates positively
with age, and negatively with the estimated creatinine clearance.
6. Limitations of the study
Our ﬁndings are based on a single center study with a relatively
small sample size of the cohort. Moreover, the current study
has not evaluated the response of patients with ED to phos-
phodiesterase-5 inhibitors. Similarly, measurement and
replacement of testosterone was not performed. Furthermore,
penile vascular duplex was not performed to exclude caverno-
sal arterial or tissue disease, or venous leak as possible under-
lying causes of ED. Finally, the exclusive enrollment of
patients with multi-vessel CAD limits the generalization of
the ﬁndings to all diabetic patients with ED undergoing elec-
tive catheterization in real-world practice.
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